Editors and writers independently select products unless marked Sponsored or Promoted. Sponsored content is a paid ad, while content marked Promoted is chosen by Ziff Davis leadership. We may earn an ...

NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET, with hosts ...

Roche has dipped its toe in the M&A water with an agreement to buy US biotech 89bio and its late-stage candidate for metabolic dysfunction-associated steatohepatitis (MASH). The $14.50-per-share deal ...

This make-ahead mashed potato recipe is a game changer for holiday hosts. Cooking Thanksgiving dinner can feel like a game of Tetris, but this method lets you make mashed potatoes up to 2 days ahead ...

Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis (MASH) for $4.7 billion upfront, shortly after claiming FDA approval to ...